Navigation Links
Past gains in reducing risk of heart disease have flattened, women especially affected

NEW ORLEANS - The positive U.S. health trend documented over the past 30 years of reduction in risk for heart disease is not as strong as is widely perceived - and, in fact, the trend has flattened, according to a new analysis of national data by Mayo Clinic.

This suggests that the public health challenge of curbing heart disease may be greater than is commonly thought, says Francisco Lopez-Jimenez, M.D., cardiologist and lead researcher.

"This study may surprise people because the data show that the risk of heart disease is not going down as we expected," he says. "The estimated risk in our nation was coming down nicely in the 1980s. Then around 2000 it began changing - the trend lines flattened. While we had done a nice job with lowering cholesterol, blood pressure and stopping smoking, over time the improvement in these risk factors slowed and others like diabetes and obesity emerged, threatening to undo the early progress we made in reducing risk of heart disease. Most of the gains in reducing heart disease risk have been offset by the increased prevalence of diabetes and obesity."

Dr. Lopez-Jimenez presents the findings today at the American Heart Association's Scientific Sessions 2008 in New Orleans.


The study is the first to suggest that not as much progress against heart disease is being made in recent years, despite the efforts by many organizations to promote healthy lifestyles, and the wide availability and lower price of many cholesterol and blood pressure-lowering drugs. "This is highly relevant to public health because most people think the risk of heart disease is going down steadily and has for the past 30 to 40 years - but our data show something different," Dr. Lopez-Jimenez says. "The fact is that despite all the wonderful things we've done - all the changes in fat consumption, the promotion of exercise, the quitting smoking, treatment of high cholesterol and blood pressure - it doesn't appear to be enough; the risk reduction we did achieve early on in the 1980s has gone flat, and we need to change that."

The researchers compared national heart disease risk factor data from three time periods to track change over time in risk reduction. The early period documented changes in risk between 1976 and 1980 and a midpoint of 1988 to 1994. The last period documented changes in risk from the midpoint to 1999 - 2004. Comparing changes from the early stage to the midpoint documented a decline in the overall risk to develop heart disease; but comparing change from the midpoint to the late period showed the trend flattening.

"No one has ever compared national data this way, which is why we are the first to detect this worrisome flattening of the trend in risk factor reduction," Dr. Lopez-Jimenez says.

Key Findings

The data show that, in the U.S., the average age-adjusted 10-year risk of heart disease:

  • Decreased from 10 percent to 7.9 percent between the early period and the midpoint - a strong showing of progress in controlling risk factors during the 1980s.
  • Decreased only minimally in the interval from the midpoint to the last period, from 7.9 percent to 7.4 percent. This documents the flattening of the healthy trend.

For women, in particular, the age-adjusted risk declined from the early period to the midpoint, but stayed flat from the midpoint to the late period, Dr. Lopez-Jimenez says. Similarly, when age groups were compared, the average predicted risk for those ages 30 to 49 stayed flat from the midpoint to the late period compared to people age 50 and above, he says.


Contact: Traci Klein
Mayo Clinic

Related medicine news :

1. Two Antioxidant Vitamins Dont Protect Against Heart Disease
2. AMA to Support Laws Against Text Messaging While Driving
3. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
4. MTVs Staying Alive Marks Ten Years of Empowering Young People in Their Fight against HIV and AIDS
5. Aspirin Doesnt Guard Diabetics Against Heart Disease
6. Activity Against MRSA is the Most Important Attribute Influencing Physicians Antibiotic Selection for the Treatment of Skin and Skin Structure Infections
7. Preeclampsia Might Protect Against Testicular Cancer
8. Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Readers Digest for Exemplifying the Fight Against Breast Cancer
9. Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer
10. National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer
11. Rowenta, Iron Manufacturer, Pits Marines, Quilters, Mothers and Daughters Against One Another to Help Iron Out Breast Cancer
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: